Lumican deficiency dysregulates trophoblast function via PI3K/AKT and P53 signaling in preeclampsia
- 1College of Pharmacy, Jining Medical University, Jining, China
Abstract
Lumican, an extracellular matrix (ECM) component highly expressed in placenta, is implicated in preeclampsia (PE) pathogenesis, though its precise mechanisms in trophoblast function and PE development remain unclear. Transcriptomic analysis of a PE rat model induced by L-NAME revealed altered placental gene expression. Lumican expression progressively increased throughout rat and human gestation but was significantly downregulated in PE patient and model placentas. Functional assays showed shRNA-mediated lumican knockdown inhibited trophoblast proliferation, migration, and invasion while promoting apoptosis. This knockdown also influenced the phosphorylation of key proteins within the PI3K/AKT and P53 signaling pathways. Co-treatment with the PI3K agonist 740 Y-P activated this pathway, enhancing trophoblast proliferation and invasion, effects antagonized by lumican knockdown. In vivo, adenovirus-mediated lumican shRNA induced PE-like phenotypes: elevated systolic blood pressure, increased 24 h urinary protein, higher plasma sFlt-1 levels and sFlt-1/PlGF ratio. Histopathological analyses demonstrated abnormal placental villi development and renal glomerular endothelial damage. Immunohistochemistry confirmed lumican deficiency reduced PI3K, AKT, and MDM2 while upregulating P53 in placental tissues. Collectively, our findings demonstrate that reduced lumican expression contributes to PE by impairing trophoblast function via disruption of the PI3K/AKT and P53 signaling pathway, thus providing a mechanistic basis for its further exploration as a diagnostic marker and therapeutic target.
Related
- Hypoxia-Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia.
- Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer
- Maternal Cardiac Function During Pregnancy in Predicting Preeclampsia: A Narrative Review
- Sugar-Specific Modulation of Trophoblast Function and Bioenergetics Under Metabolic Stress Conditions
- FUBP1 lactylation suppresses trophoblast function in fetal growth restriction.
BibTeX
@article{wang2026lumican,
title = {{Lumican deficiency dysregulates trophoblast function via PI3K/AKT and P53 signaling in preeclampsia}},
author = {Xin Wang and Qi Zhang and Yi Ren and Kunzheng Fan and Chao Liu and Huijie Gao},
journal = {NPJ Regenerative Medicine},
year = {2026},
month = jul,
doi = {10.1038/s41536-026-00493-8},
url = {https://doi.org/10.1038/s41536-026-00493-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lumican deficiency dysregulates trophoblast function via PI3K/AKT and P53 signaling in preeclampsia
AU - Xin Wang
AU - Qi Zhang
AU - Yi Ren
AU - Kunzheng Fan
AU - Chao Liu
AU - Huijie Gao
PY - 2026
DA - 2026/07/07
JO - NPJ Regenerative Medicine
DO - 10.1038/s41536-026-00493-8
UR - https://doi.org/10.1038/s41536-026-00493-8
AB - Lumican, an extracellular matrix (ECM) component highly expressed in placenta, is implicated in preeclampsia (PE) pathogenesis, though its precise mechanisms in trophoblast function and PE development remain unclear. Transcriptomic analysis of a PE rat model induced by L-NAME revealed altered placental gene expression. Lumican expression progressively increased throughout rat and human gestation but was significantly downregulated in PE patient and model placentas. Functional assays showed shRNA-mediated lumican knockdown inhibited trophoblast proliferation, migration, and invasion while promoting apoptosis. This knockdown also influenced the phosphorylation of key proteins within the PI3K/AKT and P53 signaling pathways. Co-treatment with the PI3K agonist 740 Y-P activated this pathway, enhancing trophoblast proliferation and invasion, effects antagonized by lumican knockdown. In vivo, adenovirus-mediated lumican shRNA induced PE-like phenotypes: elevated systolic blood pressure, increased 24 h urinary protein, higher plasma sFlt-1 levels and sFlt-1/PlGF ratio. Histopathological analyses demonstrated abnormal placental villi development and renal glomerular endothelial damage. Immunohistochemistry confirmed lumican deficiency reduced PI3K, AKT, and MDM2 while upregulating P53 in placental tissues. Collectively, our findings demonstrate that reduced lumican expression contributes to PE by impairing trophoblast function via disruption of the PI3K/AKT and P53 signaling pathway, thus providing a mechanistic basis for its further exploration as a diagnostic marker and therapeutic target.
SN - 2057-3995
ER -